Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 01 04:00PM ET
0.6600
Dollar change
-0.0310
Percentage change
-4.49
%
Index- P/E- EPS (ttm)-1.70 Insider Own15.16% Shs Outstand12.42M Perf Week-4.64%
Market Cap7.83M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.54M Perf Month3.53%
Income-11.37M PEG- EPS next Q- Inst Own1.77% Short Float1.31% Perf Quarter-4.82%
Sales0.14M P/S55.94 EPS this Y- Inst Trans-13.23% Short Ratio1.10 Perf Half Y-38.89%
Book/sh0.69 P/B0.96 EPS next Y- ROA-91.52% Short Interest0.14M Perf Year-40.00%
Cash/sh0.07 P/C9.55 EPS next 5Y- ROE-258.00% 52W Range0.41 - 2.45 Perf YTD-43.10%
Dividend Est.- P/FCF- EPS past 5Y12.78% ROI-133.46% 52W High-73.06% Beta0.82
Dividend TTM- Quick Ratio0.33 Sales past 5Y2003.75% Gross Margin-45.84% 52W Low62.84% ATR (14)0.07
Dividend Ex-DateSep 16, 2013 Current Ratio0.33 EPS Y/Y TTM55.94% Oper. Margin-6259.36% RSI (14)52.93 Volatility11.61% 13.91%
Employees19 Debt/Eq0.33 Sales Y/Y TTM-82.19% Profit Margin-8339.01% Recom3.00 Target Price20.20
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q86.93% Payout- Rel Volume1.28 Prev Close0.69
Sales Surprise- EPS Surprise- Sales Q/Q1817.53% Earnings- Avg Volume125.87K Price0.66
SMA2010.55% SMA502.86% SMA200-29.44% Trades Volume160,867 Change-4.49%
Oct-22-24 08:45AM
Aug-15-24 07:30AM
Jul-18-24 10:31AM
Jul-09-24 07:16AM
Jul-02-24 09:00AM
09:00AM Loading…
Jun-25-24 09:00AM
Jun-12-24 09:20AM
May-24-24 09:00AM
May-22-24 09:00AM
May-17-24 10:52PM
May-15-24 11:14AM
09:25AM
May-09-24 09:35AM
Apr-18-24 09:25AM
Apr-17-24 09:00AM
08:30AM Loading…
Apr-10-24 08:30AM
Mar-26-24 08:30AM
Mar-21-24 08:30AM
Mar-19-24 08:30AM
Mar-14-24 09:30AM
Feb-27-24 08:30AM
Feb-15-24 08:30AM
Feb-12-24 08:30AM
Feb-08-24 09:17AM
Jan-03-24 07:24AM
Dec-07-23 08:30AM
Dec-05-23 08:30AM
Nov-21-23 08:30AM
Nov-16-23 10:05AM
Nov-15-23 09:00AM
08:30AM Loading…
Oct-26-23 08:30AM
Oct-17-23 08:30AM
Oct-09-23 08:30AM
Aug-23-23 08:30AM
Aug-17-23 09:19AM
Aug-10-23 08:30AM
Aug-07-23 08:30AM
Aug-03-23 09:20AM
Aug-01-23 08:30AM
Jul-31-23 09:30AM
Jul-27-23 09:22AM
Jul-26-23 08:30AM
Jul-24-23 12:30PM
Jul-06-23 08:30AM
Jun-26-23 08:30AM
Jun-20-23 08:30AM
Jun-12-23 08:30AM
Jun-06-23 08:30AM
May-22-23 08:30AM
May-04-23 08:30AM
Apr-26-23 08:30AM
Apr-10-23 08:30AM
Apr-06-23 08:30AM
Mar-31-23 06:49PM
Mar-20-23 07:00AM
Mar-14-23 07:00AM
Feb-28-23 08:30AM
Feb-23-23 04:16PM
Feb-21-23 08:30AM
Jan-19-23 08:30AM
Jan-18-23 08:25AM
Jan-05-23 08:30AM
Dec-20-22 11:05AM
Nov-17-22 08:30AM
05:16AM
Nov-14-22 06:20PM
Nov-07-22 08:30AM
Nov-02-22 08:30AM
Oct-05-22 08:30AM
Sep-23-22 08:30AM
Sep-16-22 09:36AM
Sep-13-22 08:30AM
Sep-09-22 08:30AM
Aug-22-22 08:30AM
Aug-18-22 08:30AM
Aug-15-22 05:48PM
Aug-02-22 08:30AM
Jul-18-22 08:30AM
Jul-13-22 08:30AM
Jul-06-22 08:30AM
Jun-30-22 08:30AM
Jun-21-22 08:30AM
Jun-16-22 08:30AM
Jun-10-22 08:30AM
Jun-07-22 01:10PM
Jun-01-22 08:30AM
May-25-22 08:30AM
May-23-22 07:30AM
May-16-22 05:46PM
03:25PM
May-13-22 08:30AM
May-12-22 09:00AM
08:30AM
May-10-22 08:30AM
May-05-22 08:30AM
May-03-22 08:30AM
Apr-28-22 08:30AM
Apr-26-22 08:30AM
Mar-31-22 04:18PM
Mar-23-22 09:25AM
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.